Case report · 10 Aug 2026
Conference abstractPublished 27 Jul 2015
Pre-surgical hemodynamic planning of reconstructive congenital heart surgery- Design of clinical trials to asses image-guided pre-surgical planning
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Approximately 1 in 100 children are born with a clinically significant and complex congenital cardiac defect representing 47,000 children each year in the EU and 1,500,000 children worldwide. In order to survive, these patients usually require at least 2 or more consecutive open-heart surgery stages. During these surgical stages, the abnormal great vessel anatomy is reconstructed in three-dimensions using native tissue and artificial materials. Achieving optimal blood flow distribution (hemodynamics) through the reconstructed surgical pathway is essential for healthy multi-organ physiology (cerebral, pulmonary, renal and gastrointestinal systems) which in turn will result improved post-operative quality-of-life and neurodevelopment. Unfortunately it is not possible for the surgeon to guarantee the best flow-split unless a sophisticated bioengineering analysis is performed for each patient. This analysis leads to a patient-specific hemodynamic performance report where numerical values for several hemodynamic parameters are computed and include the systemic to pulmonary flow split, pulsatile flow quality indices and flow-based vascular reactivity maps and systolic to diastolic pressure ratios. Through this approach a large number of surgical configurations can be analyzed for each patient in the computer before in vivo execution. In the present talk, we will discuss this procedure through case studies, validation tests and recent developments featuring its applicability. We will highlight the challenges of designing a clinical trial to prove the benefit of this simulation-based approach which includes scaling problems due to patient-size and cardiac output, complex sensitivity analysis of a large number of parameters. Finally we will propose a clinical research study design that can prove the efficacy of the proposed hemodynamic analysis technique for complex congenital heart cases. Thus better quality and longer life expectancy might be presented to many complex congenital heart patients with these efforts.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kerem Pekkan”
- BylineArticles whose byline prints “Tijen Alkan Bozkaya”
